Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Oddoux, J. Struewing, C. Clayton, S. Neuhausen, L. Brody, M. Kaback, B. Haas, L. Norton, P. Borgen, S. Jhanwar, D. Goldgar, H. Ostrer, K. Offit (1996)
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%Nature Genetics, 14
B. Alter (1995)
Hematologic abnormalities in Fanconi anemia.Blood, 85 4
(2003)
Heterogeneity in Fanconi anemia: evidence for two new genetic subtypes
A. Auerbach, Q. Liu, R. Ghosh, M. Pollack, G. Douglas, H. Broxmeyer (1990)
Prenatal identification of potential donors for umbilical cord blood transplantation for Fanconi anemiaTransfusion, 30
A. D’Andrea, M. Grompe (2003)
The Fanconi anaemia/BRCA pathwayNature Reviews Cancer, 3
A. Savoia, M. Centra, L. Ianzano, G. Cillis, L. Zelante, M. Buchwald (1995)
Characterization of the 5' region of the Fanconi anaemia group C (FACC) gene.Human molecular genetics, 4 8
S. Mazoyer, A. Dunning, O. Serova, J. Dearden, N. Puget, C. Healey, S. Gayther, J. Mangion, M. Stratton, H. Lynch, D. Goldgar, B. Ponder, G. Lenoir (1996)
A polymorphic stop codon in BRCA2Nature Genetics, 14
O. Levran, Tamar Erlich, N. Magdalena, J. Gregory, S. Batish, P. Verlander, A. Auerbach (1997)
Sequence variation in the Fanconi anemia gene FAA.Proceedings of the National Academy of Sciences of the United States of America, 94 24
H. Hanenberg, H. Hanenberg, S. Batish, K. Pollok, K. Pollok, L. Vieten, P. Verlander, C. Leurs, R. Cooper, R. Cooper, K. Göttsche, L. Haneline, D. Clapp, S. Lobitz, David Williams, David Williams, A. Auerbach (2002)
Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool.Experimental hematology, 30 5
S. Wolf, J. Kahn, J. Wagner (2003)
Using Preimplantation Genetic Diagnosis to Create a Stem Cell Donor: Issues, Guidelines & LimitsThe Journal of Law, Medicine & Ethics, 31
S. Neuhausen, T. Gilewski, L. Norton, T. Tran, P. McGuire, J. Swensen, H. Hampel, P. Borgen, K. Brown, M. Skolnick, D. Shattuck-Eidens, S. Jhanwar, D. Goldgar, K. Offit (1996)
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancerNature Genetics, 13
Y. Verlinsky, S. Rechitsky, W. Schoolcraft, C. Strom, A. Kuliev (2001)
Preimplantation diagnosis for Fanconi anemia combined with HLA matching.JAMA, 285 24
A. Meetei, J. Winter, A. Medhurst, M. Wallisch, Q. Waisfisz, H. Vrugt, A. Oostra, Zhijiang Yan, Chen Ling, C. Bishop, M. Hoatlin, H. Joenje, Weidong Wang (2003)
A novel ubiquitin ligase is deficient in Fanconi anemiaNature Genetics, 35
R. Gibson, N. Morgan, L. Goldstein, I. Pearson, I. Kesterton, N. Foot, S. Jansen, C. Havenga, T. Pearson, T. Ravel, R. Cohn, I. Marques, I. Dokal, I. Roberts, J. Marsh, S. Ball, R. Milner, J. Llerena, E. Samochatova, S. Mohan, Pushpa Vasudevan, F. Birjandi, A. Hajianpour, M. Murer-Orlando, C. Mathew (1996)
Novel mutations and polymorphisms in the Fanconi anemia group C geneHuman Mutation, 8
C. Strathdee, A. Duncan, M. Buchwald (1992)
Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9Nature Genetics, 1
A. Gillio, P. Verlander, S. Batish, P. Giampietro, A. Auerbach (1997)
Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry study.Blood, 90 1
(2003)
Hematopoietic cell transplantation in the treatment of Fanconi anemia
JE Wagner, ML MacMillan, AD. Auerbach (2003)
Hematopoietic Cell Transplanta-tion
P. Verlander, A. Kaporis, Qian Liu, Qiao Zhang, U. Seligsohn, A. Auerbach (1995)
Carrier frequency of the IVS4 + 4 A-->T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population.Blood, 86 11
H. Joenje, K. Patel (2001)
The emerging genetic and molecular basis of Fanconi anaemiaNature Reviews Genetics, 2
P. Verlander, Jean Lin, M. Udono, Qiao Zhang, R. Gibson, C. Mathew, A. Auerbach (1994)
Mutation analysis of the Fanconi anemia gene FACC.American journal of human genetics, 54 4
Michael Whitney, H. Saito, P. Jakobs, R. Gibson, R. Moses, M. Grompe (1993)
A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi JewsNature Genetics, 4
K. Offit, O. Levran, Brian Mullaney, K. Mah, K. Nafa, S. Batish, Raffaella Diotti, H. Schneider, Amie Deffenbaugh, T. Scholl, V. Proud, M. Robson, L. Norton, N. Ellis, H. Hanenberg, A. Auerbach (2003)
Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia.Journal of the National Cancer Institute, 95 20
J. Foe, M. Rooimans, L. Bosnoyan-Collins, N. Alon, M. Wijker, L. Parker, J. Lightfoot, M. Carreau, D. Callen, A. Savoia, N. Cheng, C. Berkel, M. Strunk, J. Gille, G. Pals, F. Kruyt, J. Pronk, F. Arwert, M. Buchwald, H. Joenje (1996)
Erratum: Expression cloning of a cDNA for the major Fanconi anaemia gene, FAANature Genetics, 14
A. Butturini, A. Butturini, A. Butturini, R. Gale, R. Gale, R. Gale, P. Verlander, P. Verlander, P. Verlander, B. Adler‐Brecher, B. Adler‐Brecher, B. Adler‐Brecher, A. Gillio, A. Gillio, A. Gillio, A. Auerbach, A. Auerbach, A. Auerbach (1994)
Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study.Blood, 84 5
P. Giampietro, Jessica Davis, B. Adler‐Brecher, P. Verlander, A. Auerbach, Steven Pavlakis (1993)
The need for more accurate and timely diagnosis in Fanconi anemia: a report from the International Fanconi Anemia Registry.Pediatrics, 91 6
B. Hirsch, A. Shimamura, L. Moreau, S. Baldinger, Maha Hag-alshiekh, B. Bostrom, S. Sencer, A. D’Andrea (2004)
Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood.Blood, 103 7
M. Wajnrajch, J. Gertner, Zilla Huma, J. Popovic, Karen Lin, P. Verlander, S. Batish, Phillip Giampietro, Jessica Davis, M. New, A. Auerbach (2001)
Evaluation of Growth and Hormonal Status in Patients Referred to the International Fanconi Anemia RegistryPediatrics, 107
H. Joenje, A. Oostra, M. Wijker, F. Summa, C. Berkel, M. Rooimans, W. Ebell, M. Weel, J. Pronk, M. Buchwald, F. Arwert (1997)
Evidence for at least eight Fanconi anemia genes.American journal of human genetics, 61 4
A. Auerbach (1994)
Umbilical cord blood transplants for genetic disease: diagnostic and ethical issues in fetal studies.Blood cells, 20 2-3
C. Strathdee, H. Gavish, W. Shannon, M. Buchwald (1992)
Cloning of cDNAs for Fanconi's anaemia by functional complementationNature, 356
O Levran, T Erlich, N Magdalena (1997)
Sequence variation in the Fanconi anemia gene FAAProc Natl Acad Sci USA, 94
K Offit, O Levran, B Mullaney (2003)
Shared Genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia in an extended familyJ Natl Cancer Inst, 95
N. Kauff, P. Pérez-Segura, M. Robson, Lauren Scheuer, B. Siegel, A. Schluger, B. Rapaport, T. Frank, K. Nafa, N. Ellis, G. Parmigiani, K. Offit (2002)
Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer familiesJournal of Medical Genetics, 39
T. Yamashita, N. Wu, G. Kupfer, C. Corless, H. Joenje, M. Grompe, A. D’Andrea (1996)
Clinical variability of Fanconi anemia (type C) results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity.Blood, 87 10
D. Kutler, Bhuvanesh Singh, J. Satagopan, S. Batish, M. Berwick, P. Giampietro, H. Hanenberg, A. Auerbach (2003)
A 20-year perspective on the International Fanconi Anemia Registry (IFAR).Blood, 101 4
P. Rosenberg, M. Greene, B. Alter (2003)
Cancer incidence in persons with Fanconi anemia.Blood, 101 3
N. Howlett, T. Taniguchi, S. Olson, B. Cox, Q. Waisfisz, C. Die-Smulders, N. Persky, M. Grompe, H. Joenje, G. Pals, H. Ikeda, E. Fox, A. D’Andrea (2002)
Biallelic Inactivation of BRCA2 in Fanconi AnemiaScience, 297
J. Wagner, J. Tolar, O. Levran, T. Scholl, Amie Deffenbaugh, J. Satagopan, L. Ben-Porat, K. Mah, S. Batish, D. Kutler, M. MacMillan, H. Hanenberg, A. Auerbach (2004)
Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia.Blood, 103 8
Satkiran Grewal, J. Kahn, M. MacMillan, N. Ramsay, J. Wagner (2004)
Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype-identical sibling selected using preimplantation genetic diagnosis.Blood, 103 3
J. Foe, M. Rooimans, L. Bosnoyan-Collins, N. Alon, M. Wijker, L. Parker, J. Lightfoot, M. Carreau, D. Callen, A. Savoia, N. Cheng, C. Berkel, M. Strunk, J. Gille, G. Pals, F. Kruyt, J. Pronk, F. Arwert, M. Buchwald, H. Joenje (1996)
Expression cloning of a cDNA for the major Fanconi anaemia gene, FAANature Genetics, 14
AD. Auerbach (2003)
Current Protocols in Human Genetics
(1995)
Haplotype analysis of polymorphic markers surrounding the Fanconi anemia gene FAC: evidence for a founder effect for the IVS4 +4A>T mutation
AD Auerbach, M Buchwald, H. Joenje (2002)
The Genetic Basis of Human Cancer
J. Foe, M. Barel, Peter Thuß, M. Digweed, F. Arwert, H. Joenje (1996)
Sequence variations in the Fanconi anaemia gene, FAC: pathogenicity of 1806insA and R548X and recognition of D195V as a polymorphic variantHuman Genetics, 98
S. Apostolou, S. Whitmore, J. Crawford, G. Lennon, G. Sutherland, D. Callen, Leonarda lanzano, M. Savino, M. d’Apolito, Angelo Notarangeio, E. Memeo, M. Piemontese, L. Zelante, A. Savoia, R. Gibson, A. Tipping, N. Morgan, S. Hassock, S. Jansen, T. Ravel, Carola Berkell, J. Pronk, D. Easton, C. Mathew, O. Levran, P. Verlander, S. Batish, Tamar Erlich, A. Auerbach, A. Cleton-Jansen, E. Moerland, C. Cornelisse, N. Doggett, L. Deaven, R. Moyzis (1996)
Positional cloning of the Fanconi anaemia group A geneNature Genetics, 14
A. Auerbach (1993)
Fanconi anemia diagnosis and the diepoxybutane (DEB) test.Experimental hematology, 21 6
P. Giampietro, P. Verlander, Jessica Davis, A. Auerbach (1997)
Diagnosis of Fanconi anemia in patients without congenital malformations: an international Fanconi Anemia Registry Study.American journal of medical genetics, 68 1
Samuel Shapiro (1998)
Pharmacoepidemiology: An IntroductionAnnals of Internal Medicine, 129
Fanconi anemia (FA) should be included among the genetic diseases that occur at high frequency in the Ashkenazi Jewish population. FA exhibits extensive genetic heterogeneity; there are currently 11 complementation groups reported, and 8 (i.e., FANCA, FANCC, FANCD1/BRCA2, FANCD2, FANCE, FANCF, FANCG, and FANCL) genes have been isolated. While patients may be from widely diverse ethnic groups, a single mutation in complementation group FA-C, c.711+4A>T (commonly known as IVS4+4A>T prior to current nomenclature rules) is unique to FA patients of Ashkenazi Jewish ancestry, and has a carrier frequency of greater than 1/100 in this population. In addition, a mutation (c.65G>A) in FANCA (FA-A is the most common complementation group in non-Jewish patients) and the mutation c.6174delT in FANCD1/BRCA2 are also unique to the Ashkenazi Jewish population. Therefore, the study of Fanconi anemia can lend insight into the types of cancer-predisposing genetic diseases specific to the Ashkenazi.
Familial Cancer – Springer Journals
Published: Dec 30, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.